Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2014 16:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Presentations Featuring T2Candida and T2Dx at IDWeek 2014

LEXINGTON, Mass., Oct. 7, 2014 (GLOBE NEWSWIRE) -- T2 Biosystems (Nasdaq:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that the T2Candida®...
September 22, 2014 17:08 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Receives FDA Authorization to Market T2Candida and T2Dx for the Detection of Sepsis-Causing Pathogens

– Novel test to identify Candida, one of the most lethal forms of common bloodstream infections that cause sepsis, faster than current methods – hours instead of days – –...
September 02, 2014 06:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems to Present at the Morgan Stanley Global Healthcare Conference

LEXINGTON, Mass., Sept. 2, 2014 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq:TTOO) today announced that John McDonough, president and chief executive officer, is scheduled to present at the Morgan...
August 12, 2014 13:00 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Closing of Initial Public Offering

LEXINGTON, Mass., Aug. 12, 2014 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (Nasdaq:TTOO) today announced the closing of its initial public offering of 5,980,000 shares of its common stock at an initial...
August 07, 2014 06:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Announces Pricing of Initial Public Offering

LEXINGTON, Mass., Aug. 7, 2014 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. today announced the pricing of its initial public offering of 5,200,000 shares of common stock at a public offering price of...